Antisense c-myc retroviral vector suppresses established human prostate cancer

Human Gene Therapy

Volumn 9, Issue 5, 1998, Pages 747-755

  Steiner, Mitchell S ^a,b,c   Anthony, Catherine T ^a   Lu, Yi ^b   Holt, Jeffrey T ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; COMPLEMENTARY RNA; MESSENGER RNA; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE THERAPY; HISTOPATHOLOGY; HUMAN; MALE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; NUDE MOUSE; ONCOGENE C MYC; PROMOTER REGION; PROSTATE CANCER; RETROVIRUS; TUMOR VOLUME;

ANIMALIA; MAMMARY TUMOR ONCOVIRUS; MAMMARY TUMOR VIRUS; MOUSE MAMMARY TUMOR VIRUS; MUS MUSCULUS; ONCOVIRINAE; RNA VIRUSES; TUMOR VIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0032549552     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.5-747     Document Type: Article

References (17)

1. AMATI, B., LITTLEWOOD, T.D., EVAN, G.I., and LAND, H. (1993). The c-myc protein induces cell cycle progression and apoptosis through dimerization with max. EMBO J. 12, 5083-5087.
2. BISSONNETTE, R.P., ECHEVERRI, F., MAHBOUBI, A., and GREEN, D.R. (1992). Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359, 552-554.
3. BUTTYAN, R., SAWCZUK, I.S., BENSON, M.C., SIEGAL, J.D., and OLSSON, C.A. (1987). Enhanced expression of the c-myc protooncogene in high-grade human prostate cancers. Prostate 11, 327-337.
4. CATO, A.C., WEINMANN, J., MINK, S., PONTA, H., HENDERSON, D., and SONNENBERG, A. (1989). The regulation of expression of mouse mammary tumor virus DNA by steroid hormones and growth factors. J. Steroid Biochem. 34, 139-143.
5. COOKE, D.E., QUARMBY, V.E., MICKEY, D.D., ISAACS, J.T., and FRENCH, F.S. (1988). Oncogene expression in prostate cancer: Dunning R3327 rat dorsal prostatic adenocarcinoma system. Prostate 13, 263-272.
6. EVAN, G.I., and LITTLEWOOD, T.D. (1993). The role of c-myc in cell growth. Curr. Opin. Genet. Dev. 3, 44-49.
7. FLEMING, W.H., HAMEL, A., MACDONALD, R., RAMSEY, E., PETTIGREW, N.M., JOHNSTON, B., DODD, J.G., and MATUSIK, R.J. (1986). Expression of the c-myc protooncogene in human prostatic carcinoma and benign prostatic hyperplasia. Cancer Res. 46, 1535-1538.
8. FORNARI, F.A., JR., JARVIS, W.D., GRANT, S., ORR, M.S., RANDOLPH, J.K., WHITE, F.K.H., MUMAW, V.R., LOVINGS, E.T., FREEMAN, R.H., and GERWIRTZ, D.A. (1994). Induction of differentiation and growth arrest associated with nascent (nonoligosomal) DNA fragmentation and reduced c-myc expression in MCF-7 human breast tumor cells after continuous exposure to sublethal concentration of doxorubicin. Cell Growth & Differ. 5, 723-733.
9. HESTON, W.D.W. (1997). Gene therapy or fruit and vegetables? A biased perspective on prostatic carcinogenesis and hypothetical approaches to its control. Mol. Urol. 1, 11-20.
10. HOLT, J.T. (1993). Antisense rescue defines specialized and generalized functions for c-fos protein during cell growth. Mol. Cell. Biol. 13, 3820-3821.
11. HOLT, J.T., REDNER, R.L., and NIENHIUS, A.W. (1988). An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation. Mol. Cell. Biol. 8, 963-973.
12. JOTTE, R.M., KAMATA, N., and HOLT, J.T. (1994). Myristylation- and differention-dependent transactivation by FBR v-fos is antagonized by C/EBP. J. Biol. Chem. 269, 16383-16396.
13. LU, Y., WHITAKER, L.L., LI, X., LOTAN, D., and LOTAN, R. (1995). Coexpression of galectin-1 and its comlementary glycoconjugates laminin and lysosome-associated membrane proteins in murine PCC4.aza1R embryonal carcinoma cells induced to differentiate by butyrate. Mol. Cell. Diff. 3, 175-191.
14. LUNA, L.G. (1960). Manual of Histologic Staining Methods of the Armed Forces Institute of Pathology. (McGraw-Hill Company, New York) p. 38.
15. STEINER, M.S., and BARRACK, E.R. (1992). Transforming growth factor-β1 overproduction in prostate cancer: Effects on growth in vitro and in vivo. Mol. Endocrinol. 6, 15-25.
16. STEINER, M.S., SATTERWHITE, D.J., and MOSES, H.L. (1995). Molecular insights into altered cell cycle regulation and genitourinary malignancy. Urol. Oncol. 1, 3-17.
17. STEWART, B.W. (1994). Mechanisms of apoptosis: Integration of genetic, biochemical, and cellular indicators. J. Natl. Cancer Inst. 86, 1286-1296.